GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
GSK PLC closed 18.56% below its 52-week high of £18.24, which the company reached on May 16th.
Peptide-drug Conjugate Market Report Introduction 2 Peptide-drug Conjugate Market Executive Summary 3 Competitive Landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback